Nurotoxic sterol glycosides
US9573972B2 · kind B2 · utility
0Cited by
17References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2009 |
| Grant date | Feb 21, 2017 |
| Priority date | — |
| Expiry date | Oct 30, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/035
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to compositions for use in animal models of neurodegenerative disease and methods therefor. More particularly, the invention relates to the use of neurotoxic sterol glycosides or neurotoxic glycolipids, or combinations thereof, in animal models of neurodegenerative disease. Neurotoxicity-modulating chromenols can also be used in these animal models in combination with the neurotoxic sterol glycosides or neurotoxic glycolipids, or combinations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.